-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RW0xMO8Ou8xtgi8jNzSDVWGcyq4x5m+SFJ4k/hsclDhOhBzGBS87mGxhegTqrWJA d1/j2AVqWwQoAfRLx+ND1g== 0000719598-99-000004.txt : 19990513 0000719598-99-000004.hdr.sgml : 19990513 ACCESSION NUMBER: 0000719598-99-000004 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990331 FILED AS OF DATE: 19990512 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOLECULAR BIOSYSTEMS INC CENTRAL INDEX KEY: 0000719598 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363078632 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 5 SEC ACT: SEC FILE NUMBER: 001-10546 FILM NUMBER: 99617575 BUSINESS ADDRESS: STREET 1: 10030 BARNES CANYON RD CITY: SAN DIEGO STATE: CA ZIP: 92121-2789 BUSINESS PHONE: 6198127001 MAIL ADDRESS: STREET 1: 10030 BARNES CANYON ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 COMPANY DATA: COMPANY CONFORMED NAME: DITTRICH HOWARD CENTRAL INDEX KEY: 0001065156 STANDARD INDUSTRIAL CLASSIFICATION: [] OFFICER STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 10070 BARNES CANYON BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 5 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. [ ] Form 3 Holdings Reported [ ] Form 4 Transactions Reported 1. Name and Address of Reporting Person(s) Dittrich, Howard 10030 Barnes Canyon Blvd. San Diego, CA 92121 2. Issuer Name and Ticker or Trading Symbol Molecular Biosystems, Inc. (MB) 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) 4. Statement for Month/Year 03/99 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ ] Director [ ] 10% Owner [X] Officer (give title below) [ ] Other (specify below) Vice President, Research, Medical, & Regulatory Affairs 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of action action or Disposed of (D) Securities Indirect Date Code A Beneficially D Beneficial (Month/ or Owned at or Ownership Day/Year) Code Amount D Price End of Year I - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 12/01/98 A 20,000 (1) A 25,593 D Direct Table II (PART 1) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and Security or Exercise action action Securities Acquired (A) Expiration Date Price of Date Code or Disposed of (D) Derivative Security Code A D Exercisable Expiration - ------------------------------------------------------------------------------------------------------------------------------------ Incentive Stock Option (right $2.7500 01/21/99 A 65,000 01/21/00 (2) 01/21/09 to buy) Incentive Stock Option (right $9.6875 05/12/98 A 10,322 04/01/99 05/12/08 to buy) Non-Qualified Stock Option $3.3125 11/17/98 A 40,000 11/17/99 11/17/08 (right to buy) Non-Qualified Stock Option $9.6875 05/12/98 A 15,978 04/01/99 05/12/08 (right to buy) Table II (PART 2) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of Security action of Underlying of Deri- Derivative Indirect Date Securities vative Securities D Beneficial Amount or Security Beneficially or Ownership Number of Owned at I - Title Shares End of Year - ------------------------------------------------------------------------------------------------------------------------------------ Incentive Stock Option (right 01/21/99 Common Stock 65,000 65,000 D Direct to buy) Incentive Stock Option (right 05/12/98 Common Stock 10,322 10,322 D Direct to buy) Non-Qualified Stock Option 11/17/98 Common Stock 40,000 40,000 D Direct (right to buy) Non-Qualified Stock Option 05/12/98 Common Stock 15,978 15,978 D Direct (right to buy) Explanation of Responses: (1) Restricted stock grant which vests on February 1, 2000 (2) Options vest in equal yearly installments of 25% beginning 1/21/00.
SIGNATURE OF REPORTING PERSON /S/ Dittrich, Howard DATE -----END PRIVACY-ENHANCED MESSAGE-----